[1]
2006. Telithromycin (Ketek®)in lower respiratory tract infections: economic aspects . Farmeconomia. Health Economics and Therapeutic Pathways. 7, 2 (Sep. 2006), 89–96. DOI:https://doi.org/10.7175/fe.v7i2.679.